SS Innovations Reports Second Quarter 2026 Financial Results
SS Innovations reported record Q2 revenue of $13.9 million, up 39.4% year-over-year, driven by a 40.8% increase in system sales and expanding global adoption. Operational metrics accelerated significantly with 30 new system installations and 2,528 surgeries performed during the quarter, representing increases of 30.4% and 142.6% respectively.
Key figures
- Revenue
- 13939709
- Guidance
- Expects FDA 510(k) review completion by end of Q1 2027; targets EU CE marking certification by end of 2026
- Revenue Yoy
- 39.4%
- Rd expense
- 2395694
- Gross margin
- 50.9%
- Gross profit
- 7100950
- Q2 surgeries
- 2528
- Q2 installations
- 30
- Cash and equivalents
- 13647430
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.